Organon & Co. (OGN) Cash Flow Statement
Organon & Co. (OGN) generated $737.0M of operating cash flow over the twelve months to 2026-06-30, spent $170.0M on capital expenditure and had free cash flow of $567.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OGNOrganon & Co.Follow OGN — free
—
Price chart with a free account
- Market cap
- 3.6B
- P/E TTM
- 17.6
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 9 Nov, in 15 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.16 | 0.86 | 0.80 | 0.94 | 0.70 | 0.74 | |
| Capital expenditure | 0.19 | 0.20 | 0.25 | 0.18 | 0.16 | -0.17 | |
| Free cash flow | 1.97 | 0.66 | 0.55 | 0.76 | 0.54 | 0.57 | |
| Dividends paid | 0.15 | 0.29 | 0.29 | 0.30 | 0.09 | — | |
| Stock-based compensation | 0.06 | 0.08 | 0.10 | 0.11 | 0.08 | — |
USD billions · SEC XBRL
Organon & Co. — questions
- What is Organon & Co.'s operating cash flow?
- $737.0M over the twelve months to 2026-06-30.
- How much does Organon & Co. spend on capital expenditure?
- $170.0M over the twelve months to 2026-06-30.
- What is Organon & Co.'s free cash flow?
- $567.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Organon & Co.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.